Regional Training Center Mutengene
Â
Mr Ngang Paul
Administrator
Mrs. Fai Bridget Yehgeh
Assistant Administrator for Finance
Overview
Health Services Complex (HSC) Mutengene is one of the outstanding institutions of the Cameroon Baptist Convention (CBC) Health Services created in 2001. The Health Services Complex is host to many sub-units or services working in synergy to impact lives in line with the CBC Health Services’ mission statement. The staff capacity of HSC is 192 as at August 30, 2020
Our Services
Services Offered
- AIDS Care and Prevention Programme (ACP)
- Central Pharmacy
- National Early Infant Diagnosis Referral Laboratory (EID)
- CBC Regional Training Centre for Excellence (CBC, RTC)
- Health Management Information System (HMIS)
- Rest House Services
- Security Services
- Chaplaincy Services
- Technical Services
- Staff Canteen
- Sports Infrastructure
Administrator
Mr. Ngang Paul  Makwondoh
Assistant Administrator for Finance
Mrs. Fai Bridget Yehgeh
 Projects
The CBC Health Services intends to develop the Regional Training Centre for Excellence into a School of Public Health and a Centre for Excellence in Health Capacity Building. It also plans to Automate Pharmaceutical processes into 7 new pharmaceutical factories (7 Pharmaceutical production lines).
Investment Areas
- Pharmaceutical production Units
- Small Volume Sterile liquid dosage forms
- Large volume parenteral preparation
- Oral solid dosage form (Tablets and Capsules)
- Oral Liquid Dosage Forms
- Topical semi-solid dosage forms
- Laboratory
- Bottling potable water
- Sanitary products (Liquid and solid soaps)
Location
The Health Services Complex (HSC) is located in Mutengene, South West Region of Cameroon. It is at Dibanda Hill along the Mutengene-Buea Road.
Contact Information
 CBC Central Pharmacy
P.O. Box 152, Tiko
Southwest Region, CameroonÂ
Tel: +237 33351096
Email:Â cpinfo@cbchealthservices.org
Website: www.cbchealthservices.org
Central pharmacy mutengene
Invest with Central Pharmacy, Mutengene !!!
 Following government accreditation obtained in march 2017, CP is determined to expand, automate and introduce new pharmaceutical producrion lines